← FDA Drug Approvals (Drugs@FDA)
CHABELINA FE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2020-04-15
Drug application
- FDA Application #
ANDA202962- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CHABELINA FE
- Generic name
- NDAC AND EE TABLETS AND FERROUS FUMARATE TABLETS
- Active ingredients
- ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
- Dosage form
- TABLET
- Route
- ORAL-28
- Marketing status
- Prescription
- Sponsor
- NOVAST LABS
- Manufacturer
- Mayne Pharma Inc.
- First approval
- 2020-04-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown